Global Animal Antibiotics and Antimicrobials Market Size 2024, Forecast To 2033
14 Feb, 2024
The animal antibiotics and antimicrobials market has displayed strong growth, escalating from $4.97 billion in 2023 to $5.34 billion in 2024, boasting a compound annual growth rate (CAGR) of 7.5%. This growth is attributed to disease outbreaks, livestock production growth, regulatory policies, and increased consumer awareness. The market is anticipated to see strong growth, reaching $7.08 billion in 2028, with a CAGR of 7.3%. Contributing factors include emerging diseases, global population growth, regulatory changes, and public health concerns. Key trends encompass alternative solutions, collaborative initiatives, customized treatment plans, rising investments in research, and the integration of blockchain technology.
Global Animal Antibiotics and Antimicrobials Market Key Driver
The animal antibiotics and antimicrobials market experiences growth due to the increasing demand for animal-derived food products. Global meat and poultry consumption is projected to reach 313 million metric tons in 2023. Companies focus on maintaining healthy, disease-free herds using antibiotics and antimicrobials. The demand for animal-derived food products fuels the growth of the animal antibiotics and antimicrobials market.
Get A Free Sample Of The Global Animal Antibiotics and Antimicrobials Market ReportGlobal Animal Antibiotics and Antimicrobials Market Segments
The animal antibiotics and antimicrobials market covered in this report is segmented –
1) By Type of Product: Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicrobials and Antibiotics
2) By Mode of Delivery: Premixes, Oral Powder, Oral Solution, Injection, Other Modes of Delivery
3) By Animal Type: Food-Producing Animals, Companion Animals
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North Americawas the largest region in the animal antibiotics and antimicrobials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Animal Antibiotics and Antimicrobials Industry Players
C. H. Boehringer Sohn AG & Co. KG; Zoetis Inc.; Elanco Animal Health Inc.; Merck & Co. Inc.; Phibro Animal Health Corp.; Ashish Life Science Pvt. Limited; Ayurvet Limited; Dechra Pharmaceuticals Plc; Endovac Animal Health; HIPRA S. A.; Huvepharma Inc.; Inovet (V. M. D. nv/sa); Kyoritsu seiyaku Corporation; Lutim Pharma Private Limited; Neogen Corporation; Tianjin Ringpu Bio-Technology Co. Ltd.; UCBVET Animal Health; Vetoquinol; Virbac; Zydus Animal Health Limited; China Animal Husbandry Co. Ltd.; ECO Animal Health Ltd.; Nicosia International; Norbrook Laboratories Limited; Biovet AD - Peshtera; BioChek B. V.; Bio Agri Mix LP; Bio-Medical Research Ltd.; Bioiberica S. A. U.; Ceva Santé Animale
Get The Full Global Animal Antibiotics and Antimicrobials Market Report
Animal Antibiotics and Antimicrobials Market Overview
The animal antibiotics and antimicrobials refer to veterinary medications that work against bacteria or microorganisms by either killing bacteria/microorganisms or limiting their development and multiplication. These medications are used in animals to treat clinical diseases, to prevent or control common disease events, and enhance animal growth.
Animal Antibiotics and Antimicrobials Global Market Report 2023 provides data on the global animal antibiotics and antimicrobials market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The animal antibiotics and antimicrobials market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.